| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.606 | 0.003 | 0.606 | Interleukin 2 agonist | 0.473 0.012 DBMET00301 0.587 0.004 DBMET00014 0.521 0.006 DBMET01043 0.452 0.015 DBMET01045 0.467 0.013 DBMET01046 | ||
| 0.502 | 0.025 | 0.502 | GABA C receptor rho-3 antagonist | 0.246 0.158 DBMET00301 0.324 0.1 DBMET00014 0.386 0.068 DBMET01043 | ||
| 0.462 | 0.013 | 0.64 | Peroxidase inhibitor | 0.409 0.019 DBMET00301 0.283 0.041 DBMET00014 0.216 0.055 DBMET01043 0.64 0.004 DBMET01045 0.595 0.005 DBMET01046 | DBMET01045 | |
| 0.442 | 0.029 | 0.458 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.458 0.026 DBMET00014 0.416 0.035 DBMET01043 | DBMET00014 | |
| 0.424 | 0.015 | 0.529 | Interleukin agonist | 0.251 0.078 DBMET00301 0.529 0.007 DBMET00014 0.299 0.048 DBMET01043 0.317 0.04 DBMET01045 0.345 0.03 DBMET01046 | DBMET00014 | |
| 0.406 | 0.01 | 0.665 | Phospholipase C inhibitor | 0.215 0.035 DBMET00301 0.291 0.019 DBMET00014 0.222 0.032 DBMET01043 0.599 0.004 DBMET01045 0.665 0.003 DBMET01046 | DBMET01046 | |
| 0.367 | 0.009 | 0.367 | Interleukin 6 antagonist | 0.188 0.049 DBMET00301 0.24 0.025 DBMET00014 0.204 0.038 DBMET01043 | ||
| 0.392 | 0.048 | 0.392 | Aldehyde oxidase inhibitor | |||
| 0.398 | 0.058 | 0.42 | Thioredoxin glutathione reductase inhibitor | 0.355 0.075 DBMET00014 0.42 0.05 DBMET01043 | DBMET01043 | |
| 0.335 | 0.005 | 0.335 | Ca(v)2.2 blocker | 0.168 0.024 DBMET00014 0.156 0.027 DBMET01043 0.076 0.069 DBMET01046 | ||
| 0.327 | 0.006 | 0.327 | Carbonic anhydrase XV inhibitor | 0.126 0.043 DBMET00301 0.299 0.008 DBMET00014 0.196 0.019 DBMET01043 | ||
| 0.371 | 0.052 | 0.371 | 5 Hydroxytryptamine release stimulant | |||
| 0.311 | 0.005 | 0.311 | MAP kinase kinase 3 inhibitor | 0.227 0.061 DBMET00301 0.259 0.024 DBMET00014 0.25 0.031 DBMET01043 | ||
| 0.305 | 0.007 | 0.305 | DNA directed RNA polymerase inhibitor | 0.146 0.025 DBMET00301 0.157 0.022 DBMET00014 0.155 0.023 DBMET01043 | ||
| 0.322 | 0.024 | 0.322 | Tyrosine 3 hydroxylase inhibitor | 0.26 0.059 DBMET00301 0.228 0.093 DBMET00014 0.254 0.064 DBMET01043 0.179 0.178 DBMET01045 | ||
| 0.329 | 0.033 | 0.329 | 5 Hydroxytryptamine uptake stimulant | 0.207 0.139 DBMET00014 0.24 0.091 DBMET01043 | ||
| 0.319 | 0.028 | 0.319 | RNA-directed DNA polymerase inhibitor | 0.168 0.157 DBMET00301 0.209 0.087 DBMET00014 0.22 0.073 DBMET01043 | ||
| 0.31 | 0.019 | 0.31 | Lipocortins synthesis antagonist | 0.257 0.031 DBMET00301 0.203 0.054 DBMET00014 0.237 0.038 DBMET01043 | ||
| 0.294 | 0.013 | 0.315 | 3C-like protease (Human coronavirus) inhibitor | 0.315 0.009 DBMET00014 0.236 0.034 DBMET01043 | DBMET00014 | |
| 0.283 | 0.003 | 0.283 | Nicotinamide phosphoribosyltransferase inhibitor | 0.118 0.006 DBMET00301 0.186 0.004 DBMET00014 0.17 0.004 DBMET01043 | ||
| 0.338 | 0.064 | 0.46 | Immunomodulator | 0.258 0.108 DBMET00014 0.36 0.057 DBMET01045 0.46 0.029 DBMET01046 | DBMET01046 | |
| 0.282 | 0.011 | 0.282 | GABA C receptor agonist | 0.122 0.048 DBMET00301 0.1 0.067 DBMET00014 0.183 0.024 DBMET01043 | ||
| 0.269 | 0.002 | 0.348 | Dihydropteroate synthase inhibitor | 0.139 0.004 DBMET00301 0.285 0.001 DBMET00014 0.348 0.001 DBMET01043 0.078 0.007 DBMET01046 | DBMET01043 | |
| 0.372 | 0.127 | 0.372 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.323 0.183 DBMET00014 0.276 0.248 DBMET01043 | ||
| 0.251 | 0.016 | 0.251 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.144 DBMET00301 0.234 0.025 DBMET00014 0.195 0.07 DBMET01043 | ||
| 0.257 | 0.025 | 0.257 | Cyclooxygenase inhibitor | 0.162 0.061 DBMET00301 0.127 0.091 DBMET00014 0.162 0.061 DBMET01043 | ||
| 0.238 | 0.007 | 0.238 | HIV-1 reverse transcriptase inhibitor | 0.063 0.056 DBMET00301 0.125 0.02 DBMET00014 0.094 0.034 DBMET01043 | ||
| 0.254 | 0.024 | 0.254 | Histone acetyltransferase inhibitor | 0.197 0.074 DBMET00014 0.238 0.031 DBMET01043 | ||
| 0.268 | 0.039 | 0.268 | DNA methyltransferase I inhibitor | 0.152 0.102 DBMET00301 0.25 0.047 DBMET00014 0.148 0.106 DBMET01043 0.14 0.116 DBMET01045 0.245 0.049 DBMET01046 | ||
| 0.233 | 0.005 | 0.233 | Adenylate cyclase stimulant | 0.187 0.021 DBMET00301 0.176 0.029 DBMET00014 0.179 0.027 DBMET01043 0.126 0.112 DBMET01045 0.14 0.081 DBMET01046 | ||
| 0.264 | 0.045 | 0.264 | ErbB-1 antagonist | 0.23 0.064 DBMET00014 | ||
| 0.246 | 0.034 | 0.255 | Amyloid beta precursor protein antagonist | 0.218 0.047 DBMET00014 0.255 0.031 DBMET01045 | DBMET01045 | |
| 0.221 | 0.011 | 0.221 | Carbonic anhydrase VI inhibitor | 0.103 0.037 DBMET00301 0.152 0.02 DBMET00014 0.13 0.026 DBMET01043 | ||
| 0.301 | 0.091 | 0.301 | Calcium channel activator | 0.226 0.177 DBMET01043 | ||
| 0.22 | 0.013 | 0.224 | Carbonic anhydrase III inhibitor | 0.144 0.031 DBMET00301 0.224 0.012 DBMET00014 0.15 0.029 DBMET01043 | DBMET00014 | |
| 0.231 | 0.025 | 0.231 | NADPH oxidase inhibitor | 0.179 0.041 DBMET00014 | ||
| 0.234 | 0.03 | 0.235 | Acetylcholine M1 receptor antagonist | 0.165 0.062 DBMET00014 0.235 0.029 DBMET01043 | DBMET01043 | |
| 0.229 | 0.025 | 0.229 | Cyclooxygenase 1 inhibitor | 0.19 0.039 DBMET00301 0.111 0.089 DBMET00014 0.183 0.042 DBMET01043 | ||
| 0.216 | 0.013 | 0.216 | Adenylate kinase inhibitor | 0.128 0.037 DBMET00301 0.115 0.048 DBMET00014 0.145 0.028 DBMET01043 0.122 0.042 DBMET01045 0.147 0.027 DBMET01046 | ||
| 0.246 | 0.044 | 0.249 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 DBMET00301 0.221 0.057 DBMET00014 0.249 0.043 DBMET01043 | DBMET01043 | |
| 0.226 | 0.024 | 0.226 | Cyclooxygenase 2 inhibitor | 0.146 0.057 DBMET00301 0.107 0.095 DBMET00014 0.156 0.05 DBMET01043 | ||
| 0.266 | 0.065 | 0.266 | Superoxide dismutase inhibitor | 0.17 0.155 DBMET01043 0.191 0.127 DBMET01046 | ||
| 0.205 | 0.006 | 0.205 | DOPA decarboxylase inhibitor | 0.129 0.035 DBMET00301 0.126 0.039 DBMET00014 0.186 0.009 DBMET01043 | ||
| 0.2 | 0.004 | 0.2 | 5 Hydroxytryptamine 6 antagonist | 0.182 0.004 DBMET00301 0.102 0.014 DBMET00014 0.107 0.013 DBMET01043 | ||
| 0.2 | 0.005 | 0.2 | Acetylcholine release stimulant | 0.097 0.093 DBMET00301 0.153 0.015 DBMET00014 0.149 0.017 DBMET01043 | ||
| 0.198 | 0.005 | 0.198 | Glutamate release inhibitor | 0.088 0.066 DBMET00301 0.103 0.038 DBMET00014 0.108 0.032 DBMET01043 | ||
| 0.225 | 0.033 | 0.225 | Succinate dehydrogenase inhibitor | 0.145 0.123 DBMET00301 0.166 0.085 DBMET00014 0.173 0.076 DBMET01043 | ||
| 0.313 | 0.123 | 0.313 | 15-Lipoxygenase inhibitor | 0.256 0.159 DBMET00014 0.247 0.167 DBMET01043 | ||
| 0.259 | 0.069 | 0.259 | Gastrin inhibitor | 0.241 0.09 DBMET00014 | ||
| 0.241 | 0.053 | 0.241 | DNA methylase inhibitor | 0.209 0.074 DBMET00014 0.145 0.122 DBMET01045 0.241 0.054 DBMET01046 | ||
| 0.216 | 0.029 | 0.216 | Toll-Like receptor 9 antagonist | 0.149 0.064 DBMET00014 0.139 0.071 DBMET01043 | ||
| 0.198 | 0.013 | 0.198 | GABA C receptor antagonist | 0.149 0.03 DBMET00301 0.1 0.079 DBMET00014 0.131 0.042 DBMET01043 | ||
| 0.187 | 0.004 | 0.187 | Potassium channel (ATP-sensitive) blocker | 0.066 0.048 DBMET00301 0.178 0.004 DBMET00014 0.101 0.015 DBMET01043 | ||
| 0.238 | 0.059 | 0.238 | MAP kinase kinase 2 inhibitor | 0.207 0.077 DBMET00014 | ||
| 0.199 | 0.023 | 0.199 | Ferrochelatase inhibitor | 0.175 0.029 DBMET00014 | ||
| 0.294 | 0.118 | 0.371 | Calpain 2 inhibitor | 0.371 0.076 DBMET00014 | DBMET00014 | |
| 0.207 | 0.032 | 0.279 | Alpha-N-acetylglucosaminidase inhibitor | 0.279 0.019 DBMET00014 0.108 0.09 DBMET01043 | DBMET00014 | |
| 0.185 | 0.012 | 0.185 | NADH dehydrogenase inhibitor | 0.1 0.044 DBMET00301 0.095 0.049 DBMET00014 0.114 0.032 DBMET01043 | ||
| 0.181 | 0.008 | 0.181 | Toll-Like receptor 3 antagonist | 0.116 0.032 DBMET00014 0.102 0.048 DBMET01043 | ||
| 0.318 | 0.145 | 0.417 | Transcription factor inhibitor | 0.232 0.2 DBMET00301 0.402 0.108 DBMET00014 0.417 0.103 DBMET01043 | DBMET01043 | |
| 0.204 | 0.033 | 0.204 | 5 Hydroxytryptamine antagonist | |||
| 0.186 | 0.016 | 0.186 | Carbonic anhydrase XIII inhibitor | 0.076 0.053 DBMET00301 0.145 0.023 DBMET00014 0.108 0.034 DBMET01043 | ||
| 0.173 | 0.005 | 0.173 | Glycine receptor agonist | 0.099 0.021 DBMET00301 0.098 0.022 DBMET00014 0.115 0.014 DBMET01043 | ||
| 0.18 | 0.012 | 0.181 | Carbonic anhydrase inhibitor | 0.072 0.039 DBMET00301 0.181 0.011 DBMET00014 0.089 0.031 DBMET01043 0.076 0.037 DBMET01046 | DBMET00014 | |
| 0.173 | 0.009 | 0.173 | MAP kinase kinase 1 inhibitor | 0.15 0.017 DBMET00301 0.143 0.019 DBMET00014 0.111 0.045 DBMET01043 | ||
| 0.177 | 0.013 | 0.207 | Potassium channel activator | 0.207 0.008 DBMET00014 0.101 0.047 DBMET01043 | DBMET00014 | |
| 0.17 | 0.008 | 0.17 | CC chemokine 6 receptor antagonist | 0.128 0.08 DBMET00301 0.138 0.045 DBMET00014 0.14 0.041 DBMET01043 | ||
| 0.221 | 0.059 | 0.221 | Nitric-oxide synthase stimulant | 0.172 0.147 DBMET00014 0.186 0.115 DBMET01043 | ||
| 0.178 | 0.017 | 0.178 | HIV-1 integrase (Overall Integration) inhibitor | 0.098 0.056 DBMET00014 0.095 0.059 DBMET01043 | ||
| 0.195 | 0.034 | 0.195 | Mannose-6-phosphate isomerase inhibitor | 0.187 0.038 DBMET01043 | ||
| 0.243 | 0.082 | 0.252 | 5 Hydroxytryptamine 1E antagonist | 0.252 0.072 DBMET00014 | DBMET00014 | |
| 0.197 | 0.037 | 0.227 | Hexokinase inhibitor | 0.227 0.023 DBMET00014 | DBMET00014 | |
| 0.257 | 0.102 | 0.257 | Nootropic | |||
| 0.181 | 0.029 | 0.181 | Neuropeptide Y1 antagonist | 0.178 0.031 DBMET00014 0.135 0.09 DBMET01043 | ||
| 0.159 | 0.008 | 0.159 | Carbonic anhydrase VB inhibitor | 0.069 0.029 DBMET00301 0.119 0.013 DBMET00014 0.085 0.02 DBMET01043 | ||
| 0.179 | 0.03 | 0.179 | Cathepsin H inhibitor | 0.143 0.051 DBMET00014 0.129 0.065 DBMET01043 0.111 0.087 DBMET01046 | ||
| 0.186 | 0.038 | 0.186 | GABA C receptor rho-2 antagonist | 0.133 0.1 DBMET01043 | ||
| 0.183 | 0.035 | 0.254 | MAP kinase kinase inhibitor | 0.254 0.015 DBMET00301 0.128 0.066 DBMET00014 0.156 0.048 DBMET01043 | DBMET00301 | |
| 0.154 | 0.006 | 0.161 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.056 0.044 DBMET00301 0.161 0.005 DBMET00014 0.095 0.019 DBMET01043 | DBMET00014 | |
| 0.162 | 0.017 | 0.162 | Triose-phosphate isomerase inhibitor | 0.135 0.025 DBMET00301 0.093 0.056 DBMET00014 0.111 0.038 DBMET01043 | ||
| 0.306 | 0.162 | 0.436 | DNA polymerase beta inhibitor | 0.436 0.105 DBMET00014 0.223 0.209 DBMET01043 | DBMET00014 | |
| 0.211 | 0.069 | 0.211 | Anesthetic general | 0.173 0.092 DBMET00014 | ||
| 0.157 | 0.019 | 0.157 | Porphobilinogen synthase inhibitor | 0.075 0.051 DBMET01043 | ||
| 0.147 | 0.01 | 0.152 | Carbonic anhydrase II inhibitor | 0.063 0.033 DBMET00301 0.152 0.01 DBMET00014 0.076 0.027 DBMET01043 0.058 0.036 DBMET01046 | DBMET00014 | |
| 0.156 | 0.019 | 0.156 | GABA C receptor rho-1 antagonist | 0.099 0.064 DBMET01043 | ||
| 0.204 | 0.068 | 0.204 | I kappa B kinase epsilon inhibitor | 0.164 0.105 DBMET00014 | ||
| 0.138 | 0.007 | 0.138 | Ca(v)3.1 blocker | 0.1 0.022 DBMET00014 0.088 0.039 DBMET01043 | ||
| 0.145 | 0.015 | 0.152 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET00301 0.152 0.014 DBMET00014 0.073 0.04 DBMET01043 | DBMET00014 | |
| 0.156 | 0.026 | 0.156 | DNA repair enzyme inhibitor | 0.138 0.044 DBMET00014 0.116 0.08 DBMET01043 | ||
| 0.149 | 0.02 | 0.149 | Electrolyte absorption antagonist | 0.11 0.045 DBMET00014 0.087 0.079 DBMET01043 | ||
| 0.198 | 0.071 | 0.198 | Focal adhesion kinase 2 inhibitor | 0.146 0.137 DBMET00301 0.178 0.09 DBMET00014 | ||
| 0.172 | 0.047 | 0.172 | Alkaline phosphatase inhibitor | 0.13 0.075 DBMET00014 | ||
| 0.239 | 0.115 | 0.239 | 12-Lipoxygenase inhibitor | 0.204 0.147 DBMET00014 | ||
| 0.133 | 0.009 | 0.133 | Purinergic P2X1 antagonist | 0.058 0.046 DBMET00301 0.073 0.029 DBMET00014 0.078 0.026 DBMET01043 | ||
| 0.125 | 0.002 | 0.125 | Complement factor 1 inhibitor | 0.034 0.004 DBMET00301 0.032 0.004 DBMET00014 0.062 0.003 DBMET01043 0.017 0.013 DBMET01046 | ||
| 0.156 | 0.034 | 0.156 | Calcium channel N-type blocker | 0.129 0.053 DBMET00014 | ||
| 0.136 | 0.014 | 0.136 | Myeloperoxidase inhibitor | 0.087 0.054 DBMET00301 0.082 0.063 DBMET00014 0.077 0.073 DBMET01043 | ||
| 0.138 | 0.017 | 0.138 | Interleukin 12 antagonist | 0.124 0.026 DBMET00014 | ||
| 0.233 | 0.113 | 0.34 | Insulysin inhibitor | 0.197 0.161 DBMET00301 0.232 0.114 DBMET00014 0.339 0.038 DBMET01045 0.34 0.038 DBMET01046 | DBMET01046 | |
| 0.152 | 0.032 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.15 0.034 DBMET00014 0.121 0.071 DBMET01043 | ||
| 0.131 | 0.012 | 0.131 | Biliverdin reductase inhibitor | 0.065 0.036 DBMET00014 0.079 0.027 DBMET01043 | ||
| 0.153 | 0.034 | 0.153 | 5 Hydroxytryptamine 3A agonist | |||
| 0.132 | 0.015 | 0.14 | Carbonic anhydrase VA inhibitor | 0.064 0.054 DBMET00301 0.14 0.013 DBMET00014 0.078 0.038 DBMET01043 | DBMET00014 | |
| 0.193 | 0.077 | 0.193 | Non-steroidal antiinflammatory agent | 0.146 0.12 DBMET00014 0.154 0.11 DBMET01043 | ||
| 0.286 | 0.169 | 0.4 | DNA directed DNA polymerase inhibitor | 0.4 0.115 DBMET00014 | DBMET00014 | |
| 0.167 | 0.051 | 0.174 | Hemostatic | 0.174 0.046 DBMET00014 0.143 0.077 DBMET01046 | DBMET00014 | |
| 0.215 | 0.101 | 0.215 | DNA synthesis inhibitor | |||
| 0.146 | 0.033 | 0.146 | Photosensitizer | 0.097 0.094 DBMET00014 0.097 0.094 DBMET01043 | ||
| 0.133 | 0.022 | 0.133 | Phosphofructokinase-1 inhibitor | 0.068 0.049 DBMET00301 0.079 0.042 DBMET01043 | ||
| 0.15 | 0.041 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.129 0.123 DBMET01043 | ||
| 0.111 | 0.004 | 0.202 | Thymidylate synthase inhibitor | 0.092 0.005 DBMET00301 0.073 0.01 DBMET00014 0.076 0.009 DBMET01043 0.123 0.004 DBMET01045 0.202 0.002 DBMET01046 | DBMET01046 | |
| 0.179 | 0.074 | 0.198 | LIM domain kinase 1 inhibitor | 0.198 0.064 DBMET00014 | DBMET00014 | |
| 0.168 | 0.063 | 0.209 | Diuretic | 0.132 0.092 DBMET00014 0.209 0.041 DBMET01046 | DBMET01046 | |
| 0.157 | 0.053 | 0.157 | Calcium channel blocker | |||
| 0.138 | 0.033 | 0.138 | UDP-glucose 4-epimerase inhibitor | 0.089 0.075 DBMET00301 0.111 0.05 DBMET00014 0.104 0.057 DBMET01043 | ||
| 0.156 | 0.052 | 0.21 | M17 leucyl aminopeptidase inhibitor | 0.12 0.078 DBMET00301 0.21 0.03 DBMET00014 | DBMET00014 | |
| 0.109 | 0.006 | 0.109 | Exportin-1 inhibitor | 0.071 0.041 DBMET00014 0.074 0.035 DBMET01043 | ||
| 0.126 | 0.027 | 0.126 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.075 0.055 DBMET00014 0.08 0.051 DBMET01043 | ||
| 0.115 | 0.016 | 0.115 | D-Ala-D-Ala ligase inhibitor | 0.098 0.032 DBMET00014 0.09 0.044 DBMET01043 | ||
| 0.102 | 0.004 | 0.102 | Potassium channel (Inward rectifier) activator | 0.097 0.005 DBMET00014 0.07 0.012 DBMET01043 | ||
| 0.158 | 0.062 | 0.158 | CF transmembrane conductance regulator agonist | 0.127 0.126 DBMET00014 | ||
| 0.122 | 0.026 | 0.123 | I kappa B kinase inhibitor | 0.123 0.025 DBMET00014 0.083 0.057 DBMET01043 | DBMET00014 | |
| 0.099 | 0.004 | 0.099 | Potassium channel (ATP-sensitive) activator | 0.094 0.005 DBMET00014 0.066 0.011 DBMET01043 | ||
| 0.113 | 0.019 | 0.113 | GABA aminotransferase inhibitor | 0.077 0.05 DBMET00014 0.069 0.064 DBMET01043 | ||
| 0.1 | 0.009 | 0.113 | Nitric oxide donor | 0.073 0.029 DBMET00301 0.078 0.024 DBMET00014 0.113 0.005 DBMET01043 0.093 0.012 DBMET01045 0.096 0.011 DBMET01046 | DBMET01043 | |
| 0.112 | 0.021 | 0.112 | Phenylalanine 4-hydroxylase inhibitor | 0.09 0.031 DBMET00301 | ||
| 0.121 | 0.03 | 0.121 | Thioredoxin inhibitor | 0.093 0.058 DBMET00014 0.09 0.061 DBMET01043 0.083 0.075 DBMET01045 0.104 0.044 DBMET01046 | ||
| 0.28 | 0.189 | 0.28 | 5 Hydroxytryptamine release inhibitor | 0.258 0.216 DBMET00014 | ||
| 0.126 | 0.036 | 0.126 | Creatine kinase inhibitor | |||
| 0.108 | 0.018 | 0.108 | Carbamoyl phosphate synthetase inhibitor | 0.071 0.034 DBMET01043 | ||
| 0.12 | 0.031 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.096 | 0.008 | 0.096 | Potassium channel (Inward rectifier) blocker | 0.074 0.015 DBMET00014 | ||
| 0.105 | 0.017 | 0.105 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET00014 0.049 0.046 DBMET01043 | ||
| 0.167 | 0.08 | 0.167 | Tumour necrosis factor antagonist | 0.154 0.096 DBMET00301 | ||
| 0.096 | 0.009 | 0.121 | Macrophage elastase inhibitor | 0.121 0.007 DBMET00301 0.049 0.025 DBMET00014 0.04 0.033 DBMET01043 0.109 0.008 DBMET01045 0.075 0.013 DBMET01046 | DBMET00301 | |
| 0.133 | 0.046 | 0.357 | Aminopeptidase B inhibitor | 0.116 0.055 DBMET00301 0.091 0.072 DBMET01043 0.357 0.006 DBMET01045 0.344 0.006 DBMET01046 | DBMET01045 | |
| 0.112 | 0.025 | 0.185 | Glutamate dehydrogenase inhibitor | 0.071 0.055 DBMET00014 0.072 0.054 DBMET01043 0.133 0.019 DBMET01045 0.185 0.011 DBMET01046 | DBMET01046 | |
| 0.113 | 0.027 | 0.174 | Metalloproteinase-9 inhibitor | 0.1 0.032 DBMET00301 0.104 0.03 DBMET00014 0.066 0.064 DBMET01043 0.174 0.011 DBMET01045 0.149 0.016 DBMET01046 | DBMET01045 | |
| 0.1 | 0.014 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.082 0.034 DBMET00301 0.082 0.033 DBMET01043 | ||
| 0.162 | 0.076 | 0.261 | Heat shock protein 90 alpha antagonist | 0.161 0.076 DBMET00301 0.143 0.094 DBMET00014 0.261 0.023 DBMET01043 | DBMET01043 | |
| 0.181 | 0.096 | 0.181 | Neurotrophic factor enhancer | |||
| 0.152 | 0.067 | 0.152 | Protein kinase stimulant | 0.128 0.085 DBMET00301 0.122 0.09 DBMET00014 | ||
| 0.107 | 0.022 | 0.107 | Caspase 7 inhibitor | 0.08 0.06 DBMET00014 | ||
| 0.104 | 0.021 | 0.257 | Neutrophil collagenase inhibitor | 0.094 0.024 DBMET00301 0.088 0.027 DBMET00014 0.07 0.039 DBMET01043 0.257 0.005 DBMET01045 0.216 0.007 DBMET01046 | DBMET01045 | |
| 0.129 | 0.047 | 0.129 | Calcium channel (voltage-sensitive) blocker | 0.1 0.083 DBMET00014 | ||
| 0.091 | 0.01 | 0.091 | Transcription factor RelA inhibitor | 0.068 0.033 DBMET00014 0.073 0.024 DBMET01043 | ||
| 0.095 | 0.014 | 0.096 | I kappa B kinase 2 inhibitor | 0.096 0.014 DBMET00014 0.069 0.033 DBMET01043 | DBMET00014 | |
| 0.11 | 0.03 | 0.11 | Bromodomain-containing protein 2 inhibitor | 0.085 0.065 DBMET00014 | ||
| 0.111 | 0.033 | 0.205 | Metalloproteinase-2 inhibitor | 0.124 0.027 DBMET00301 0.104 0.036 DBMET00014 0.205 0.009 DBMET01045 0.188 0.011 DBMET01046 | DBMET01045 | |
| 0.157 | 0.08 | 0.157 | Arachidonic acid antagonist | |||
| 0.198 | 0.121 | 0.549 | Immunostimulant | 0.303 0.078 DBMET00301 0.246 0.098 DBMET00014 0.524 0.026 DBMET01045 0.549 0.023 DBMET01046 | DBMET01046 | |
| 0.143 | 0.067 | 0.143 | Amylase inhibitor | |||
| 0.116 | 0.04 | 0.116 | Nitric-oxide synthase inhibitor | 0.087 0.083 DBMET01046 | ||
| 0.078 | 0.003 | 0.078 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 DBMET00301 0.029 0.018 DBMET00014 0.043 0.006 DBMET01043 | ||
| 0.127 | 0.053 | 0.127 | Interleukin 8 antagonist | |||
| 0.112 | 0.039 | 0.126 | Potassium channel (Voltage-sensitive) activator | 0.126 0.027 DBMET00014 | DBMET00014 | |
| 0.256 | 0.183 | 0.256 | MAP kinase kinase 6 inhibitor | |||
| 0.076 | 0.005 | 0.076 | Dihydrofolate reductase inhibitor | 0.052 0.017 DBMET00014 0.045 0.027 DBMET01043 | ||
| 0.08 | 0.009 | 0.08 | Ryanodine receptor antagonist | 0.066 0.024 DBMET00301 0.063 0.029 DBMET01043 | ||
| 0.081 | 0.011 | 0.081 | DNA helicase inhibitor | 0.079 0.012 DBMET00014 0.056 0.035 DBMET01043 0.053 0.04 DBMET01046 | ||
| 0.08 | 0.009 | 0.08 | Secretase gamma inhibitor | |||
| 0.072 | 0.004 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.017 DBMET00301 0.043 0.024 DBMET00014 0.055 0.01 DBMET01043 | ||
| 0.083 | 0.016 | 0.084 | Carbonic anhydrase XIV inhibitor | 0.084 0.015 DBMET00014 | DBMET00014 | |
| 0.09 | 0.023 | 0.09 | Carbonic anhydrase IX inhibitor | 0.082 0.026 DBMET00014 | ||
| 0.094 | 0.028 | 0.094 | Calcium channel L-type blocker | 0.064 0.062 DBMET01043 | ||
| 0.126 | 0.061 | 0.126 | Acetylcholine muscarinic antagonist | 0.106 0.083 DBMET01043 | ||
| 0.13 | 0.064 | 0.13 | Nav1.3 sodium channel blocker | 0.129 0.065 DBMET00014 | ||
| 0.087 | 0.022 | 0.096 | Carbonic anhydrase I inhibitor | 0.096 0.019 DBMET00014 | DBMET00014 | |
| 0.11 | 0.045 | 0.11 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 DBMET00014 0.083 0.075 DBMET01046 | ||
| 0.1 | 0.035 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.076 | 0.013 | 0.088 | Dihydroorotate oxidase inhibitor | 0.058 0.033 DBMET00301 0.088 0.007 DBMET00014 0.052 0.045 DBMET01043 | DBMET00014 | |
| 0.085 | 0.022 | 0.094 | Collagenase 3 inhibitor | 0.094 0.017 DBMET00301 0.061 0.04 DBMET00014 0.065 0.036 DBMET01045 0.058 0.044 DBMET01046 | DBMET00301 | |
| 0.073 | 0.01 | 0.073 | Carnitine palmitoyltransferase 1B inhibitor | 0.05 0.029 DBMET00014 | ||
| 0.065 | 0.002 | 0.065 | Complement factor 1s inhibitor | 0.036 0.004 DBMET00301 0.039 0.004 DBMET00014 0.046 0.003 DBMET01043 | ||
| 0.077 | 0.014 | 0.077 | Epithelial sodium channel blocker | 0.051 0.046 DBMET00014 | ||
| 0.072 | 0.011 | 0.072 | Fructose-1,6-bisphosphatase inhibitor | 0.052 0.023 DBMET00014 0.042 0.035 DBMET01043 | ||
| 0.193 | 0.133 | 0.234 | Neuropeptide Y2 antagonist | 0.234 0.072 DBMET00014 | DBMET00014 | |
| 0.084 | 0.024 | 0.084 | Argininosuccinate synthase inhibitor | |||
| 0.09 | 0.031 | 0.185 | Matrix metalloproteinase inhibitor | 0.099 0.027 DBMET00301 0.08 0.037 DBMET00014 0.066 0.047 DBMET01043 0.185 0.01 DBMET01045 0.149 0.014 DBMET01046 | DBMET01045 | |
| 0.072 | 0.014 | 0.082 | Carbonic anhydrase IV inhibitor | 0.042 0.031 DBMET00301 0.082 0.01 DBMET00014 0.037 0.036 DBMET01043 0.059 0.02 DBMET01046 | DBMET00014 | |
| 0.065 | 0.009 | 0.065 | Alpha 1d adrenoreceptor agonist | |||
| 0.07 | 0.014 | 0.07 | Pregnane X receptor antagonist | 0.054 0.047 DBMET01043 | ||
| 0.082 | 0.027 | 0.082 | Cannabinoid CB1 receptor agonist | 0.055 0.048 DBMET00014 | ||
| 0.101 | 0.047 | 0.101 | Calcium antagonist | |||
| 0.082 | 0.027 | 0.119 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET00301 0.119 0.009 DBMET00014 0.109 0.012 DBMET01043 | DBMET00014 | |
| 0.076 | 0.022 | 0.076 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.073 | 0.02 | 0.073 | Ca(v)3.2 blocker | 0.056 0.048 DBMET00014 | ||
| 0.078 | 0.026 | 0.078 | Glutamate (mGluR6) antagonist | |||
| 0.076 | 0.024 | 0.076 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.043 0.018 DBMET00014 0.045 0.016 DBMET01043 | ||
| 0.088 | 0.036 | 0.088 | Polo-like kinase-2 inhibitor | 0.076 0.047 DBMET00014 | ||
| 0.064 | 0.012 | 0.067 | AICAR transformylase inhibitor | 0.062 0.013 DBMET00014 0.044 0.03 DBMET01043 0.067 0.011 DBMET01046 | DBMET01046 | |
| 0.074 | 0.023 | 0.127 | Matrix metalloproteinase (membrane-type) inhibitor | 0.084 0.019 DBMET00301 0.067 0.027 DBMET00014 0.062 0.031 DBMET01043 0.127 0.01 DBMET01045 0.102 0.014 DBMET01046 | DBMET01045 | |
| 0.114 | 0.063 | 0.114 | Cystathionine beta-synthase inhibitor | |||
| 0.098 | 0.047 | 0.098 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.084 | 0.033 | 0.084 | Cannabinoid receptor agonist | |||
| 0.092 | 0.043 | 0.092 | Adrenaline agonist | 0.074 0.067 DBMET00014 | ||
| 0.134 | 0.087 | 0.134 | Pregnane X receptor agonist | |||
| 0.135 | 0.088 | 0.146 | Sphingosine 1-phosphate receptor 5 antagonist | 0.146 0.067 DBMET00014 0.127 0.108 DBMET01043 | DBMET00014 | |
| 0.086 | 0.039 | 0.256 | Glutamate decarboxylase inhibitor | 0.071 0.053 DBMET00301 0.256 0.004 DBMET01045 0.229 0.005 DBMET01046 | DBMET01045 | |
| 0.053 | 0.007 | 0.055 | ATR kinase inhibitor | 0.037 0.016 DBMET00014 0.055 0.006 DBMET01043 | DBMET01043 | |
| 0.18 | 0.135 | 0.202 | Calpain inhibitor | 0.202 0.111 DBMET00014 0.198 0.115 DBMET01046 | DBMET00014 | |
| 0.2 | 0.156 | 0.2 | Prostaglandin dehydrogenase inhibitor | |||
| 0.085 | 0.041 | 0.085 | Acetylcholine M4 receptor antagonist | |||
| 0.167 | 0.123 | 0.217 | Aryl hydrocarbon receptor agonist | 0.217 0.093 DBMET00014 | DBMET00014 | |
| 0.054 | 0.011 | 0.054 | 5 Hydroxytryptamine 2B agonist | |||
| 0.235 | 0.191 | 0.235 | Antibacterial | |||
| 0.203 | 0.16 | 0.28 | Thyroid hormone antagonist | 0.28 0.104 DBMET00014 | DBMET00014 | |
| 0.088 | 0.045 | 0.088 | Thioredoxin reductase inhibitor | 0.079 0.064 DBMET00014 0.076 0.075 DBMET01043 | ||
| 0.075 | 0.032 | 0.132 | NMDA receptor agonist | 0.11 0.016 DBMET00014 0.109 0.016 DBMET01043 0.128 0.011 DBMET01045 0.132 0.011 DBMET01046 | DBMET01046 | |
| 0.06 | 0.019 | 0.06 | Sodium/calcium exchanger inhibitor | 0.049 0.036 DBMET00014 | ||
| 0.082 | 0.041 | 0.355 | Histidine decarboxylase inhibitor | 0.27 0.008 DBMET01045 0.355 0.005 DBMET01046 | DBMET01046 | |
| 0.07 | 0.029 | 0.07 | Cannabinoid CB2 receptor agonist | |||
| 0.22 | 0.18 | 0.24 | Histamine release inhibitor | 0.24 0.163 DBMET00014 | DBMET00014 | |
| 0.056 | 0.016 | 0.056 | Urate transporter 1 inhibitor | |||
| 0.074 | 0.034 | 0.074 | Acetylcholine M2 receptor antagonist | |||
| 0.052 | 0.013 | 0.057 | Diamine oxidase inhibitor | 0.057 0.011 DBMET00014 | DBMET00014 | |
| 0.235 | 0.196 | 0.289 | Alpha-glucosidase inhibitor | 0.289 0.166 DBMET00014 | DBMET00014 | |
| 0.061 | 0.023 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.057 0.031 DBMET00301 0.054 0.043 DBMET00014 | ||
| 0.195 | 0.158 | 0.278 | Thyroid hormone beta antagonist | 0.278 0.1 DBMET00014 | DBMET00014 | |
| 0.078 | 0.041 | 0.078 | Cannabinoid receptor antagonist | |||
| 0.064 | 0.027 | 0.064 | Cannabinoid CB2 receptor antagonist | 0.054 0.034 DBMET00014 | ||
| 0.076 | 0.04 | 0.076 | I kappa B kinase 1 inhibitor | |||
| 0.065 | 0.031 | 0.065 | Carbonic anhydrase XII inhibitor | 0.057 0.034 DBMET00014 | ||
| 0.08 | 0.046 | 0.08 | MAP kinase kinase 7 inhibitor | |||
| 0.103 | 0.069 | 0.103 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.065 | 0.031 | 0.065 | Beta 2 adrenoreceptor agonist | 0.062 0.041 DBMET00014 | ||
| 0.098 | 0.065 | 0.098 | Anabolic | |||
| 0.056 | 0.022 | 0.056 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET00301 | ||
| 0.037 | 0.003 | 0.037 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 DBMET00301 0.034 0.003 DBMET00014 0.025 0.005 DBMET01043 | ||
| 0.038 | 0.004 | 0.038 | Alpha 2a adrenoreceptor agonist | |||
| 0.095 | 0.062 | 0.095 | Phosphodiesterase 7B inhibitor | |||
| 0.087 | 0.054 | 0.087 | mTOR complex 2 inhibitor | |||
| 0.089 | 0.057 | 0.089 | Ornithine decarboxylase inhibitor | |||
| 0.118 | 0.086 | 0.192 | Papain-like protease (SARS coronavirus) inhibitor | 0.192 0.012 DBMET00014 | DBMET00014 | |
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | 0.044 0.012 DBMET00014 | ||
| 0.061 | 0.031 | 0.117 | Ornithine carbamoyltransferase inhibitor | 0.092 0.018 DBMET01045 0.117 0.013 DBMET01046 | DBMET01046 | |
| 0.043 | 0.013 | 0.044 | Carnitine palmitoyltransferase inhibitor | 0.044 0.012 DBMET00014 | DBMET00014 | |
| 0.076 | 0.046 | 0.131 | Aminopeptidase I inhibitor | 0.101 0.027 DBMET01045 0.131 0.016 DBMET01046 | DBMET01046 | |
| 0.059 | 0.029 | 0.059 | mTOR inhibitor | 0.056 0.032 DBMET00014 | ||
| 0.058 | 0.028 | 0.058 | Aconitate hydratase inhibitor | |||
| 0.034 | 0.005 | 0.034 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.019 DBMET01043 | ||
| 0.124 | 0.096 | 0.213 | Cytidine deaminase inhibitor | 0.126 0.094 DBMET00014 0.213 0.042 DBMET01043 | DBMET01043 | |
| 0.064 | 0.036 | 0.064 | Acetylcholine M5 receptor antagonist | |||
| 0.094 | 0.066 | 0.094 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.069 DBMET00014 | ||
| 0.044 | 0.016 | 0.044 | Integrin alpha2 antagonist | |||
| 0.055 | 0.028 | 0.078 | Antimetabolite | 0.049 0.032 DBMET00301 0.073 0.021 DBMET01045 0.078 0.02 DBMET01046 | DBMET01046 | |
| 0.076 | 0.049 | 0.076 | Vanilloid 4 agonist | |||
| 0.052 | 0.025 | 0.052 | Cytokine production stimulant | |||
| 0.076 | 0.05 | 0.076 | GABA B receptor agonist | |||
| 0.083 | 0.058 | 0.083 | Inducible nitric-oxide synthase inhibitor | |||
| 0.12 | 0.096 | 0.12 | Nav1.6 sodium channel blocker | |||
| 0.101 | 0.077 | 0.152 | Mucolytic | 0.111 0.064 DBMET00014 0.122 0.052 DBMET01045 0.152 0.031 DBMET01046 | DBMET01046 | |
| 0.045 | 0.022 | 0.045 | Dopamine D5 agonist | |||
| 0.033 | 0.01 | 0.033 | Integrin alpha2beta1 antagonist | |||
| 0.082 | 0.059 | 0.082 | CC chemokine 5 receptor agonist | |||
| 0.056 | 0.033 | 0.056 | Alpha-mannosidase inhibitor | |||
| 0.061 | 0.039 | 0.087 | Carbonic anhydrase stimulant | 0.087 0.023 DBMET01046 | DBMET01046 | |
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | 0.052 0.03 DBMET00014 | ||
| 0.056 | 0.034 | 0.092 | Matrix metalloproteinase 1 inhibitor | 0.066 0.028 DBMET00301 0.046 0.041 DBMET00014 0.092 0.016 DBMET01045 0.077 0.023 DBMET01046 | DBMET01045 | |
| 0.082 | 0.061 | 0.082 | Estrogen-related receptor beta agonist | |||
| 0.115 | 0.093 | 0.115 | Toll-Like receptor antagonist | |||
| 0.027 | 0.006 | 0.029 | Factor XIII inhibitor | 0.029 0.005 DBMET00014 0.02 0.017 DBMET01043 | DBMET00014 | |
| 0.11 | 0.089 | 0.164 | Cyclooxygenase 3 inhibitor | 0.164 0.037 DBMET00014 | DBMET00014 | |
| 0.089 | 0.068 | 0.089 | Protein kinase C zeta inhibitor | |||
| 0.132 | 0.112 | 0.132 | Heat shock protein 70 antagonist | |||
| 0.064 | 0.044 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.038 DBMET00014 | DBMET00014 | |
| 0.083 | 0.063 | 0.083 | Histamine N-methyltransferase inhibitor | |||
| 0.033 | 0.014 | 0.033 | Carnitine palmitoyltransferase 1A inhibitor | 0.029 0.02 DBMET00014 | ||
| 0.105 | 0.086 | 0.105 | Acetylcholine antagonist | |||
| 0.045 | 0.026 | 0.045 | Histamine H2 receptor agonist | |||
| 0.046 | 0.027 | 0.046 | Beta adrenoreceptor agonist | 0.045 0.033 DBMET00014 | ||
| 0.062 | 0.043 | 0.062 | Cannabinoid CB1 receptor antagonist | |||
| 0.088 | 0.07 | 0.141 | CDK2/cyclin A inhibitor | 0.141 0.03 DBMET01043 | DBMET01043 | |
| 0.106 | 0.088 | 0.106 | Cholinergic antagonist | |||
| 0.103 | 0.086 | 0.103 | Beta amyloid protein antagonist | |||
| 0.047 | 0.031 | 0.057 | Carbonic anhydrase VII inhibitor | 0.057 0.021 DBMET00014 | DBMET00014 | |
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) agonist | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.19 | 0.174 | 0.19 | Cholesterol antagonist | |||
| 0.025 | 0.01 | 0.027 | Hexokinase stimulant | 0.027 0.01 DBMET00014 | DBMET00014 | |
| 0.04 | 0.024 | 0.04 | Retinoid X receptor antagonist | |||
| 0.053 | 0.038 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.044 | 0.029 | 0.044 | Leukocyte elastase inhibitor | 0.04 0.033 DBMET00014 | ||
| 0.04 | 0.025 | 0.043 | Factor VIIa inhibitor | 0.043 0.023 DBMET00014 | DBMET00014 | |
| 0.03 | 0.014 | 0.03 | CXC chemokine 2 receptor antagonist | |||
| 0.026 | 0.011 | 0.026 | Glutamate (mGluR1a) agonist | |||
| 0.076 | 0.062 | 0.076 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.045 | 0.031 | 0.045 | Mannosidase inhibitor | |||
| 0.08 | 0.066 | 0.08 | Histamine H2 receptor antagonist | |||
| 0.05 | 0.036 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 DBMET00014 | ||
| 0.02 | 0.005 | 0.022 | CDK2/cyclin A3 inhibitor | 0.022 0.004 DBMET01043 | DBMET01043 | |
| 0.038 | 0.024 | 0.052 | Potassium channel KCNQ activator | 0.052 0.015 DBMET00014 | DBMET00014 | |
| 0.038 | 0.024 | 0.052 | Delayed rectifier potassium channel activator | 0.052 0.015 DBMET00014 | DBMET00014 | |
| 0.035 | 0.022 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.035 | 0.022 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.036 | 0.023 | 0.036 | Retinoid X alpha receptor agonist | |||
| 0.041 | 0.029 | 0.041 | Kainate receptor agonist | |||
| 0.062 | 0.05 | 0.062 | Calcium channel P-type blocker | |||
| 0.045 | 0.033 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.072 | 0.061 | 0.072 | Keratolytic | |||
| 0.03 | 0.018 | 0.03 | CDK4/cyclin D3 inhibitor | |||
| 0.178 | 0.166 | 0.178 | Lipoxygenase inhibitor | |||
| 0.025 | 0.014 | 0.025 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.058 | 0.047 | 0.06 | Cyclin D1 inhibitor | 0.06 0.042 DBMET00014 | DBMET00014 | |
| 0.025 | 0.014 | 0.025 | Prostaglandin D2 antagonist | |||
| 0.049 | 0.039 | 0.049 | Alpha 1b adrenoreceptor agonist | |||
| 0.029 | 0.019 | 0.029 | Purinergic P2Y15 antagonist | |||
| 0.116 | 0.107 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.121 0.095 DBMET00014 | DBMET00014 | |
| 0.088 | 0.079 | 0.102 | Cyclin-dependent kinase 9 inhibitor | 0.102 0.06 DBMET01043 | DBMET01043 | |
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.062 | 0.053 | 0.062 | Phosphodiesterase 4B inhibitor | |||
| 0.066 | 0.057 | 0.069 | Secretase beta inhibitor | 0.069 0.051 DBMET00014 | DBMET00014 | |
| 0.064 | 0.056 | 0.064 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.255 | 0.247 | 0.319 | Caspase 9 stimulant | 0.319 0.173 DBMET01043 | DBMET01043 | |
| 0.089 | 0.082 | 0.125 | Falcipain 3 inhibitor | 0.125 0.05 DBMET00014 | DBMET00014 | |
| 0.018 | 0.01 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 DBMET00014 | DBMET00014 | |
| 0.018 | 0.01 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 DBMET00014 | DBMET00014 | |
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.038 | 0.031 | 0.05 | AMPA 4 receptor antagonist | 0.05 0.015 DBMET01043 0.04 0.026 DBMET01046 | DBMET01043 | |
| 0.01 | 0.003 | 0.01 | CC chemokine 6 receptor agonist | |||
| 0.042 | 0.035 | 0.042 | Heme oxygenase inhibitor | |||
| 0.008 | 0.002 | 0.008 | Glucokinase regulatory protein inhibitor | |||
| 0.031 | 0.025 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.032 | 0.027 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.013 | 0.008 | 0.018 | Carbonic anhydrase XI inhibitor | 0.018 0.005 DBMET00014 | DBMET00014 | |
| 0.09 | 0.085 | 0.092 | Glutamate (mGluR7) agonist | 0.092 0.077 DBMET00014 | DBMET00014 | |
| 0.051 | 0.046 | 0.051 | Sphingosine kinase 2 inhibitor | |||
| 0.072 | 0.067 | 0.072 | Interferon agonist | |||
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.015 | 0.011 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.017 | 0.013 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.025 | 0.021 | 0.025 | Complement factor 1r inhibitor | |||
| 0.037 | 0.034 | 0.037 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.059 | 0.056 | 0.104 | Histone deacetylase inhibitor | 0.104 0.017 DBMET00301 0.08 0.031 DBMET00014 | DBMET00301 | |
| 0.027 | 0.025 | 0.027 | MAP3K8 inhibitor | |||
| 0.086 | 0.083 | 0.086 | Urease inhibitor | |||
| 0.035 | 0.033 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.053 | 0.052 | 0.053 | Alpha 2 adrenoreceptor agonist | |||
| 0.056 | 0.055 | 0.056 | Bcl-xL inhibitor | |||
| 0.163 | 0.162 | 0.279 | Peptidyltransferase inhibitor | 0.255 0.047 DBMET00014 0.267 0.04 DBMET01045 0.279 0.033 DBMET01046 | DBMET01046 | |
| 0.055 | 0.054 | 0.055 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.017 | 0.016 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.035 | 0.035 | 0.054 | Membrane dipeptidase inhibitor | 0.051 0.015 DBMET01045 0.054 0.013 DBMET01046 | DBMET01046 | |
| 0.191 | 0.191 | 0.33 | Beta lactamase inhibitor | 0.33 0.122 DBMET00014 | DBMET00014 | |
| 0.073 | 0.073 | 0.085 | Neuropeptide Y antagonist | 0.085 0.052 DBMET00014 | DBMET00014 | |
| 0.014 | 0.016 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET00301 0.022 0.008 DBMET01046 | DBMET00301 | |
| 0.035 | 0.037 | 0.039 | Oxytocin agonist | 0.039 0.032 DBMET01046 | DBMET01046 | |
| 0.037 | 0.039 | 0.037 | VCAM-1 antagonist | 0.037 0.036 DBMET01046 | DBMET01046 | |
| 0.042 | 0.044 | 0.049 | Metalloproteinase-3 inhibitor | 0.048 0.035 DBMET00301 0.049 0.034 DBMET01045 0.049 0.035 DBMET01046 | DBMET01046 | |
| 0.037 | 0.039 | 0.037 | VCAM antagonist | 0.037 0.036 DBMET01046 | DBMET01046 | |
| 0.015 | 0.019 | 0.018 | Integrin beta7 antagonist | 0.018 0.015 DBMET01046 | DBMET01046 | |
| 0.038 | 0.043 | 0.056 | Adenosine deaminase inhibitor | 0.056 0.025 DBMET00301 | DBMET00301 | |
| 0.021 | 0.028 | 0.032 | Lysine carboxypeptidase inhibitor | 0.025 0.021 DBMET01045 0.032 0.015 DBMET01046 | DBMET01046 | |
| 0.01 | 0.017 | 0.028 | Human herpes virus 5 capsid protein P40 inhibitor | 0.028 0.004 DBMET00301 0.015 0.006 DBMET01043 | DBMET00301 | |
| 0.083 | 0.091 | 0.131 | Expectorant | 0.088 0.084 DBMET00014 0.099 0.069 DBMET01045 0.131 0.044 DBMET01046 | DBMET01046 | |
| 0.031 | 0.039 | 0.047 | Histone deacetylase class I inhibitor | 0.047 0.021 DBMET00014 | DBMET00014 | |
| 0.055 | 0.064 | 0.065 | Trypsin inhibitor | 0.065 0.038 DBMET01046 | DBMET01046 | |
| 0.026 | 0.035 | 0.133 | Histone deacetylase 2 inhibitor | 0.133 0.009 DBMET00301 0.03 0.028 DBMET00014 0.031 0.026 DBMET01045 | DBMET00301 | |
| 0.114 | 0.125 | 0.169 | Heat shock protein 90 antagonist | 0.169 0.056 DBMET01043 | DBMET01043 | |
| 0.077 | 0.09 | 0.131 | Protease inhibitor | 0.118 0.049 DBMET01045 0.131 0.04 DBMET01046 | DBMET01046 | |
| 0.051 | 0.066 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.049 DBMET00014 0.056 0.048 DBMET01046 | DBMET01046 | |
| 0.081 | 0.097 | 0.091 | Bile acid receptor antagonist | 0.091 0.071 DBMET01043 | DBMET01043 | |
| 0.032 | 0.048 | 0.046 | Aggrecanase 1 inhibitor | 0.046 0.018 DBMET00301 | DBMET00301 | |
| 0.042 | 0.059 | 0.046 | CD45 antagonist | 0.046 0.045 DBMET01046 | DBMET01046 | |
| 0.069 | 0.085 | 0.242 | Glutathione S-transferase inhibitor | 0.159 0.01 DBMET01045 0.242 0.004 DBMET01046 | DBMET01046 | |
| 0.057 | 0.075 | 0.083 | Thrombin inhibitor | 0.083 0.039 DBMET01046 | DBMET01046 | |
| 0.036 | 0.053 | 0.06 | AMPA receptor antagonist | 0.06 0.025 DBMET00301 0.05 0.031 DBMET01043 | DBMET00301 | |
| 0.093 | 0.112 | 0.161 | Aldehyde dehydrogenase inhibitor | 0.161 0.041 DBMET01043 0.107 0.087 DBMET01045 | DBMET01043 | |
| 0.026 | 0.047 | 0.056 | Kainate receptor antagonist | 0.056 0.018 DBMET01046 | DBMET01046 | |
| 0.132 | 0.153 | 0.145 | Neurotensin receptor agonist | 0.145 0.113 DBMET01046 | DBMET01046 | |
| 0.035 | 0.057 | 0.049 | Cathepsin F inhibitor | 0.047 0.018 DBMET01045 0.049 0.014 DBMET01046 | DBMET01046 | |
| 0.034 | 0.057 | 0.104 | Ribonucleoside-diphosphate reductase inhibitor | 0.104 0.018 DBMET01045 0.096 0.02 DBMET01046 | DBMET01045 | |
| 0.174 | 0.197 | 0.211 | Transcription factor NF kappa B inhibitor | 0.211 0.159 DBMET01046 | DBMET01046 | |
| 0.034 | 0.058 | 0.102 | Ribonucleotide reductase inhibitor | 0.102 0.02 DBMET01045 0.095 0.022 DBMET01046 | DBMET01045 | |
| 0.009 | 0.034 | 0.035 | Aminopeptidase A inhibitor | 0.035 0.005 DBMET01045 0.029 0.006 DBMET01046 | DBMET01045 | |
| 0.015 | 0.04 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET00014 | DBMET00014 | |
| 0.015 | 0.04 | 0.031 | Cyclin E2 inhibitor | 0.031 0.018 DBMET00014 | DBMET00014 | |
| 0.044 | 0.071 | 0.064 | NMDA 2C receptor antagonist | 0.064 0.04 DBMET01043 | DBMET01043 | |
| 0.019 | 0.046 | 0.044 | Arginase inhibitor | 0.038 0.024 DBMET01045 0.044 0.019 DBMET01046 | DBMET01046 | |
| 0.088 | 0.117 | 0.161 | CDK3/cyclin E inhibitor | 0.161 0.02 DBMET00014 | DBMET00014 | |
| 0.011 | 0.048 | 0.105 | Histone deacetylase 1 inhibitor | 0.105 0.008 DBMET00301 | DBMET00301 | |
| 0.011 | 0.049 | 0.057 | Histone deacetylase 3 inhibitor | 0.057 0.01 DBMET00301 | DBMET00301 | |
| 0.08 | 0.119 | 0.117 | Alkylator | 0.117 0.071 DBMET00301 | DBMET00301 | |
| 0.044 | 0.094 | 0.134 | Catalase inhibitor | 0.134 0.03 DBMET01046 | DBMET01046 | |
| 0.021 | 0.072 | 0.075 | Toll-Like receptor 2 agonist | 0.053 0.022 DBMET01045 0.075 0.017 DBMET01046 | DBMET01046 | |
| 0.007 | 0.058 | 0.04 | VLA-4 antagonist | 0.04 0.015 DBMET01046 | DBMET01046 | |
| 0.016 | 0.068 | 0.042 | Calcium-sensing receptor agonist | 0.042 0.007 DBMET01046 | DBMET01046 | |
| 0.049 | 0.103 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.051 DBMET00014 | DBMET00014 | |
| 0.103 | 0.16 | 0.241 | Thiol protease inhibitor | 0.135 0.088 DBMET01045 0.241 0.028 DBMET01046 | DBMET01046 | |
| 0.009 | 0.069 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.007 DBMET01043 | DBMET01043 | |
| 0.087 | 0.148 | 0.192 | Histone deacetylase SIRT1 inhibitor | 0.159 0.055 DBMET00014 0.167 0.048 DBMET01045 0.192 0.033 DBMET01046 | DBMET01046 | |
| 0.035 | 0.104 | 0.065 | Cathepsin B inhibitor | 0.055 0.041 DBMET01045 0.065 0.031 DBMET01046 | DBMET01046 | |
| 0.114 | 0.184 | 0.221 | Insulin sensitizer | 0.221 0.054 DBMET01046 | DBMET01046 | |
| 0.073 | 0.147 | 0.103 | Caspase 3 inhibitor | 0.103 0.086 DBMET01046 | DBMET01046 | |
| 0.079 | 0.155 | 0.129 | Cell adhesion inhibitor | 0.129 0.059 DBMET01046 | DBMET01046 | |
| 0.005 | 0.081 | 0.028 | AMPA 1 receptor antagonist | 0.028 0.021 DBMET01046 | DBMET01046 | |
| 0.207 | 0.285 | 0.287 | MAP kinase 1 inhibitor | 0.287 0.195 DBMET01043 | DBMET01043 | |
| 0.09 | 0.189 | 0.113 | Vanilloid 1 agonist | 0.113 0.106 DBMET01046 | DBMET01046 | |
| 0.089 | 0.19 | 0.176 | Pyruvate kinase inhibitor | 0.176 0.096 DBMET01043 | DBMET01043 | |
| 0.026 | 0.127 | 0.068 | CDK1/cyclin B inhibitor | 0.068 0.04 DBMET01043 | DBMET01043 | |
| 0.031 | 0.138 | 0.053 | Cyclin H inhibitor | 0.053 0.05 DBMET01043 | DBMET01043 | |
| 0.086 | 0.195 | 0.143 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.143 0.126 DBMET00014 | DBMET00014 | |
| 0.04 | 0.15 | 0.064 | Telomerase inhibitor | 0.064 0.059 DBMET00014 | DBMET00014 | |
| 0.048 | 0.169 | 0.386 | MAP kinase 9 inhibitor | 0.386 0.006 DBMET01043 | DBMET01043 | |
| 0.079 | 0.202 | 0.139 | Phospholipase A2 inhibitor | 0.139 0.088 DBMET01046 | DBMET01046 | |
| 0.05 | 0.176 | 0.091 | Cyclin-dependent kinase 2 inhibitor | 0.091 0.081 DBMET01043 | DBMET01043 | |
| 0.029 | 0.162 | 0.061 | Carbonic anhydrase II stimulant | 0.052 0.036 DBMET01045 0.061 0.022 DBMET01046 | DBMET01046 | |
| 0.018 | 0.151 | 0.055 | Collagenase inhibitor | 0.055 0.023 DBMET00301 0.055 0.023 DBMET01045 0.049 0.035 DBMET01046 | DBMET01045 | |
| 0.137 | 0.272 | 0.253 | Antithrombotic | 0.253 0.123 DBMET01046 | DBMET01046 | |
| 0.013 | 0.148 | 0.053 | Carbonic anhydrase I stimulant | 0.039 0.024 DBMET01045 0.053 0.015 DBMET01046 | DBMET01046 | |
| 0.004 | 0.163 | 0.04 | Integrin alpha4 antagonist | 0.04 0.013 DBMET01046 | DBMET01046 | |
| 0.03 | 0.193 | 0.277 | Cyclin-dependent kinase 1 inhibitor | 0.277 0.014 DBMET01043 | DBMET01043 | |
| 0.032 | 0.196 | 0.058 | Cathepsin E inhibitor | 0.058 0.044 DBMET01046 | DBMET01046 | |
| 0.165 | 0.347 | 0.24 | Calcium channel L-type activator | 0.24 0.217 DBMET00014 | DBMET00014 | |
| 0.008 | 0.193 | 0.034 | AMPA receptor agonist | 0.034 0.027 DBMET01046 | DBMET01046 | |
| 0.061 | 0.247 | 0.147 | Folate antagonist | 0.113 0.046 DBMET01045 0.147 0.023 DBMET01046 | DBMET01046 | |
| 0.04 | 0.228 | 0.174 | Protein kinase (CK1) inhibitor | 0.174 0.051 DBMET01043 | DBMET01043 | |
| 0.01 | 0.205 | 0.192 | Cyclin E inhibitor | 0.192 0.006 DBMET01043 | DBMET01043 | |
| 0.055 | 0.261 | 0.339 | Angiogenesis stimulant | 0.318 0.043 DBMET01045 0.339 0.036 DBMET01046 | DBMET01046 | |
| 0.036 | 0.25 | 0.079 | Chymotrypsin inhibitor | 0.071 0.068 DBMET01045 0.079 0.055 DBMET01046 | DBMET01046 | |
| 0.069 | 0.289 | 0.175 | Platelet adhesion inhibitor | 0.175 0.085 DBMET01046 | DBMET01046 | |
| 0.033 | 0.256 | 0.058 | Caspase 9 inhibitor | 0.058 0.051 DBMET01046 | DBMET01046 | |
| 0.04 | 0.269 | 0.115 | Histone deacetylase class III inhibitor | 0.102 0.088 DBMET00014 0.115 0.074 DBMET01046 | DBMET01046 | |
| 0.033 | 0.287 | 0.238 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.238 0.004 DBMET01043 | DBMET01043 | |
| 0.021 | 0.277 | 0.069 | Cyclin B3 inhibitor | 0.069 0.047 DBMET01043 | DBMET01043 | |
| 0.083 | 0.341 | 0.165 | Hypoglycemic | 0.165 0.154 DBMET01046 | DBMET01046 | |
| 0.005 | 0.265 | 0.088 | Integrin antagonist | 0.039 0.031 DBMET01045 0.088 0.018 DBMET01046 | DBMET01046 | |
| 0.024 | 0.299 | 0.053 | Vanilloid 2 antagonist | 0.053 0.035 DBMET01046 | DBMET01046 | |
| 0.008 | 0.287 | 0.176 | Cyclin E1 inhibitor | 0.176 0.006 DBMET01043 | DBMET01043 | |
| 0.009 | 0.298 | 0.049 | Integrin alpha5beta1 antagonist | 0.043 0.025 DBMET01045 0.049 0.019 DBMET01046 | DBMET01046 | |
| 0.09 | 0.381 | 0.138 | Cyclin-dependent kinase 3 inhibitor | 0.138 0.13 DBMET00014 | DBMET00014 | |
| 0.005 | 0.302 | 0.085 | Histone deacetylase 5 inhibitor | 0.085 0.011 DBMET00301 | DBMET00301 | |
| 0.018 | 0.319 | 0.146 | CDK1/cyclin B1 inhibitor | 0.146 0.016 DBMET01043 | DBMET01043 | |
| 0.016 | 0.317 | 0.039 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET01045 0.039 0.019 DBMET01046 | DBMET01046 | |
| 0.008 | 0.313 | 0.049 | Histone deacetylase class IV inhibitor | 0.049 0.014 DBMET00301 | DBMET00301 | |
| 0.008 | 0.313 | 0.049 | Histone deacetylase 11 inhibitor | 0.049 0.014 DBMET00301 | DBMET00301 | |
| 0.006 | 0.313 | 0.084 | AMPA 2 receptor antagonist | 0.084 0.007 DBMET01043 | DBMET01043 | |
| 0.028 | 0.337 | 0.139 | Cyclin-dependent kinase inhibitor | 0.139 0.062 DBMET01043 | DBMET01043 | |
| 0.049 | 0.359 | 0.407 | Death-associated protein kinase 3 inhibitor | 0.407 0.016 DBMET01043 | DBMET01043 | |
| 0.102 | 0.416 | 0.318 | Apoptosis antagonist | 0.273 0.106 DBMET01045 0.318 0.074 DBMET01046 | DBMET01046 | |
| 0.041 | 0.356 | 0.093 | Transcription factor NF kappa B stimulant | 0.08 0.071 DBMET01045 0.093 0.047 DBMET01046 | DBMET01046 | |
| 0.005 | 0.325 | 0.044 | Histone deacetylase 10 inhibitor | 0.044 0.014 DBMET00301 | DBMET00301 | |
| 0.036 | 0.379 | 0.247 | Anticoagulant | 0.161 0.071 DBMET01045 0.247 0.039 DBMET01046 | DBMET01046 | |
| 0.005 | 0.369 | 0.062 | Histone deacetylase class IIa inhibitor | 0.062 0.012 DBMET00301 | DBMET00301 | |
| 0.027 | 0.401 | 0.343 | Dyrk kinase inhibitor | 0.343 0.039 DBMET01043 | DBMET01043 | |
| 0.008 | 0.382 | 0.152 | Cyclin B2 inhibitor | 0.152 0.005 DBMET01043 | DBMET01043 | |
| 0.042 | 0.422 | 0.302 | Aurora-C kinase inhibitor | 0.302 0.005 DBMET01043 | DBMET01043 | |
| 0.046 | 0.432 | 0.222 | Tumour necrosis factor alpha release inhibitor | 0.222 0.091 DBMET00301 | DBMET00301 | |
| 0.01 | 0.405 | 0.424 | MAP kinase 10 inhibitor | 0.424 0.004 DBMET01043 | DBMET01043 | |
| 0.023 | 0.421 | 0.358 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.358 0.034 DBMET01043 | DBMET01043 | |
| 0.008 | 0.417 | 0.187 | Cyclin B inhibitor | 0.187 0.004 DBMET01043 | DBMET01043 | |
| 0.035 | 0.447 | 0.436 | Interleukin antagonist | 0.169 0.105 DBMET00014 0.436 0.026 DBMET01045 0.435 0.026 DBMET01046 | DBMET01045 | |
| 0.074 | 0.49 | 0.42 | Sodium/bile acid cotransporter inhibitor | 0.399 0.017 DBMET01045 0.42 0.012 DBMET01046 | DBMET01046 | |
| 0.01 | 0.427 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 DBMET00014 | DBMET00014 | |
| 0.036 | 0.456 | 0.166 | Free radical scavenger | 0.166 0.127 DBMET01046 | DBMET01046 | |
| 0.007 | 0.434 | 0.13 | Neuraminidase inhibitor | 0.13 0.008 DBMET00014 | DBMET00014 | |
| 0.02 | 0.448 | 0.108 | Somatostatin 1 agonist | 0.098 0.035 DBMET01045 0.108 0.029 DBMET01046 | DBMET01046 | |
| 0.01 | 0.442 | 0.126 | Neuraminidase (influenza) inhibitor | 0.126 0.01 DBMET00014 | DBMET00014 | |
| 0.012 | 0.454 | 0.149 | Aminopeptidase microsomal inhibitor | 0.051 0.047 DBMET00301 0.149 0.008 DBMET01045 0.131 0.011 DBMET01046 | DBMET01045 | |
| 0.008 | 0.457 | 0.13 | Aminopeptidase N inhibitor | 0.13 0.008 DBMET01045 0.112 0.011 DBMET01046 | DBMET01045 | |
| 0.008 | 0.47 | 0.339 | Cyclin-dependent kinase 5 inhibitor | 0.339 0.007 DBMET01043 | DBMET01043 | |
| 0.032 | 0.529 | 0.172 | Vasodilator | 0.172 0.129 DBMET01046 | DBMET01046 | |
| 0.011 | 0.514 | 0.063 | MAP kinase kinase 10 inhibitor | 0.063 0.053 DBMET01043 | DBMET01043 | |
| 0.004 | 0.522 | 0.075 | Histone deacetylase class II inhibitor | 0.075 0.009 DBMET00301 | DBMET00301 | |
| 0.054 | 0.574 | 0.619 | Death-associated protein kinase 2 inhibitor | 0.179 0.055 DBMET00014 0.619 0.002 DBMET01043 | DBMET01043 | |
| 0.004 | 0.523 | 0.064 | Leukotriene A4 hydrolase inhibitor | 0.059 0.016 DBMET01045 0.064 0.014 DBMET01046 | DBMET01046 | |
| 0.014 | 0.551 | 0.105 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 DBMET01045 0.105 0.04 DBMET01046 | DBMET01046 | |
| 0.01 | 0.548 | 0.15 | Glutamate receptor antagonist | 0.15 0.051 DBMET01043 | DBMET01043 | |
| 0.008 | 0.548 | 0.044 | Growth hormone release inhibitor | 0.041 0.03 DBMET01045 0.044 0.027 DBMET01046 | DBMET01046 | |
| 0.026 | 0.568 | 0.179 | Antioxidant | 0.179 0.133 DBMET01046 | DBMET01046 | |
| 0.016 | 0.574 | 0.141 | Factor XII inhibitor | 0.141 0.015 DBMET01043 0.088 0.052 DBMET01045 0.097 0.04 DBMET01046 | DBMET01043 | |
| 0.004 | 0.571 | 0.039 | Histone deacetylase 4 inhibitor | 0.039 0.018 DBMET00301 | DBMET00301 | |
| 0.042 | 0.621 | 0.141 | Factor V inhibitor | 0.134 0.028 DBMET01045 0.141 0.023 DBMET01046 | DBMET01046 | |
| 0.03 | 0.638 | 0.138 | Hematopoietic | 0.125 0.02 DBMET01045 0.138 0.017 DBMET01046 | DBMET01046 | |
| 0.004 | 0.651 | 0.055 | Histone deacetylase class IIb inhibitor | 0.055 0.01 DBMET00301 | DBMET00301 | |
| 0.004 | 0.662 | 0.054 | Histone deacetylase 6 inhibitor | 0.054 0.01 DBMET00301 | DBMET00301 | |
| 0.003 | 0.716 | 0.041 | Complement C3a chemotactic receptor antagonist | 0.041 0.032 DBMET01046 | DBMET01046 | |
| 0.009 | 0.728 | 0.039 | ADAM10 endopeptidase inhibitor | 0.039 0.016 DBMET00301 | DBMET00301 | |
| 0.003 | 0.724 | 0.055 | GP IIb/IIIa receptor antagonist | 0.043 0.038 DBMET01045 0.055 0.03 DBMET01046 | DBMET01046 | |
| 0.004 | 0.728 | 0.061 | Selectin antagonist | 0.059 0.05 DBMET01045 0.061 0.049 DBMET01046 | DBMET01046 | |
| 0.004 | 0.728 | 0.091 | Glucagon-like peptide 1 agonist | 0.08 0.035 DBMET01045 0.091 0.027 DBMET01046 | DBMET01046 | |
| 0.015 | 0.776 | 0.063 | Adenine nucleotide translocase inhibitor | 0.06 0.029 DBMET01045 0.063 0.023 DBMET01046 | DBMET01046 | |
| 0.003 | 0.769 | 0.029 | Protocollagen prolyl hydroxylase inhibitor | 0.026 0.021 DBMET01045 0.029 0.016 DBMET01046 | DBMET01046 | |
| 0.004 | 0.771 | 0.048 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DBMET01045 0.048 0.031 DBMET01046 | DBMET01046 | |
| 0.007 | 0.791 | 0.044 | Neurotensin receptor antagonist | 0.044 0.032 DBMET01046 | DBMET01046 | |
| 0.014 | 0.809 | 0.125 | Nav1.4 sodium channel blocker | 0.115 0.057 DBMET01045 0.125 0.048 DBMET01046 | DBMET01046 | |
| 0.006 | 0.807 | 0.064 | Erythropoietin receptor agonist | 0.051 0.021 DBMET01045 0.064 0.016 DBMET01046 | DBMET01046 | |
| 0.003 | 0.822 | 0.068 | Angiotensin-converting enzyme inhibitor | 0.065 0.024 DBMET01045 0.068 0.021 DBMET01046 | DBMET01046 | |
| 0.027 | 0.85 | 0.311 | Caspase 3 stimulant | 0.311 0.073 DBMET01043 | DBMET01043 | |
| 0.037 | 0.86 | 0.451 | Death-associated protein kinase 1 inhibitor | 0.451 0.002 DBMET01043 | DBMET01043 | |
| 0.005 | 0.829 | 0.292 | Platelet antagonist | 0.185 0.113 DBMET01045 0.292 0.055 DBMET01046 | DBMET01046 | |
| 0.029 | 0.858 | 0.246 | Growth hormone agonist | 0.221 0.051 DBMET01045 0.246 0.044 DBMET01046 | DBMET01046 | |
| 0.003 | 0.84 | 0.025 | Bradykinin B2 receptor agonist | 0.025 0.023 DBMET01046 | DBMET01046 | |
| 0.006 | 0.877 | 0.038 | Cholecystokinin B agonist | 0.036 0.029 DBMET01045 0.038 0.025 DBMET01046 | DBMET01046 | |
| 0.014 | 0.912 | 0.275 | Hepatoprotectant | 0.241 0.046 DBMET01045 0.275 0.037 DBMET01046 | DBMET01046 | |
| 0.005 | 0.938 | 0.179 | Chelator | 0.174 0.029 DBMET01045 0.179 0.028 DBMET01046 | DBMET01046 | |
| 0.005 | 0.946 | 0.065 | Sirtuin 1 inhibitor | 0.065 0.051 DBMET01046 | DBMET01046 | |
| 0.005 | 0.959 | 0.279 | Thrombolytic | 0.219 0.044 DBMET01045 0.279 0.028 DBMET01046 | DBMET01046 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |